New Results
CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, Lorenz Ulrich, Charlie Fricke, Jacob Schön, Anna Kraft, Angele Breithaupt, Kerstin Wernike, Anna Michelitsch, Franziska Sick, Claudia Wylezich, Stefan O. Müller, Thomas C. Mettenleiter, Benjamin Petsch, Anca Dorhoi, Martin Beer
doi: https://doi.org/10.1101/2021.03.22.435960
Donata Hoffmann
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Björn Corleis
2Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Susanne Rauch
3CureVac AG, Tübingen, Germany
Nicole Roth
3CureVac AG, Tübingen, Germany
Janine Mühe
3CureVac AG, Tübingen, Germany
Nico Joel Halwe
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Lorenz Ulrich
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Charlie Fricke
2Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Jacob Schön
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Anna Kraft
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Angele Breithaupt
4Department of Experimental Animal Facilities and Biorisk Management, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Kerstin Wernike
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Anna Michelitsch
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Franziska Sick
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Claudia Wylezich
1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Stefan O. Müller
3CureVac AG, Tübingen, Germany
Thomas C. Mettenleiter
5Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany
Benjamin Petsch
3CureVac AG, Tübingen, Germany
Anca Dorhoi
2Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Martin Beer
2Institute of Immunology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany
Article usage
Posted March 22, 2021.
CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, Lorenz Ulrich, Charlie Fricke, Jacob Schön, Anna Kraft, Angele Breithaupt, Kerstin Wernike, Anna Michelitsch, Franziska Sick, Claudia Wylezich, Stefan O. Müller, Thomas C. Mettenleiter, Benjamin Petsch, Anca Dorhoi, Martin Beer
bioRxiv 2021.03.22.435960; doi: https://doi.org/10.1101/2021.03.22.435960
CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, Lorenz Ulrich, Charlie Fricke, Jacob Schön, Anna Kraft, Angele Breithaupt, Kerstin Wernike, Anna Michelitsch, Franziska Sick, Claudia Wylezich, Stefan O. Müller, Thomas C. Mettenleiter, Benjamin Petsch, Anca Dorhoi, Martin Beer
bioRxiv 2021.03.22.435960; doi: https://doi.org/10.1101/2021.03.22.435960
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8718)
- Bioinformatics (29127)
- Biophysics (14930)
- Cancer Biology (12048)
- Cell Biology (17353)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18266)
- Genetics (12219)
- Genomics (16765)
- Immunology (11841)
- Microbiology (28003)
- Molecular Biology (11551)
- Neuroscience (60804)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3229)
- Physiology (4939)
- Plant Biology (10383)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)